CPHI 2025: AI, the Pharma Workforce, and Reshaping Investment
Day 3 of our special show coverage of CPHI Frankfurt
False
Day 3 of our special show coverage of CPHI Frankfurt
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 12, 2026
2 min read
“Caribou’s story has taken a heartbreaking turn,” says CEO Rachel Haurwitz, with the CRISPR-focused biotech set to discontinue vispa-cel and CB-011, and reduce its workforce
October 12, 2026
5 min read
Bayer plans a $2.2 billion Ohio campus, Genentech breaks ground in Oregon, and new investments support vaccine production, downstream processing, and manufacturing in orbit
October 8, 2026
2 min read
Adicet Bio reports 12-month remission and renal response data for its allogeneic gamma delta CAR T therapy
October 7, 2026
2 min read
Mayo Clinic and Thermo Fisher launch a large-scale multi-omics resource designed to reveal disease before symptoms appear
False
Affiliations:
Specialties:
Areas of Expertise: